- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Elisabeth Kohoutek
News 7 results
Recognition
Recognition
April 12, 2022
Legal 500 EMEA 2022 Ranks King & Spalding among the Top Firms in Europe, the Middle East and Africa
Recognition
Januar 28, 2022
Legal 500 Deutschland 2022 Ranks King & Spalding Among Germany’s Leading Law Firms
In the News
Dezember 3, 2021
K&S elects 32 new partners and promotes 16 counsel across 16 cities
Events 18 results
Speaking Engagement
Webinar
Dezember 8, 2021
Talk im Turm – Impact of the new German sales law on the food and life sciences industries
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Insights 16 results
Newsletter
Februar 22, 2022
International Food Law Gazette – February 2022
Client Alert
Februar 8, 2022
Europe - Between The EU Clinical Trials Regulation And The UK Guideline On Clinical Trials
Newsletter
August 25, 2021
International Food Law Gazette – August 2021
Newsletter
Juni 1, 2021
ESG Spezial - Juni 2021